Antibody Targeting of the CC Chemokine Ligand 5 Results in Diminished Leukocyte Infiltration into the Central Nervous System and Reduced Neurologic Disease in a Viral Model of Multiple Sclerosis

Journal of Immunology

Volumn 172, Issue 7, 2004, Pages 4018-4025

  Glass, William G ^a,b   Hickey, Michelle J ^a   Hardison, Jenny L ^a   Liu, Michael T ^a   Manning, Jerry E ^a   Lane, Thomas E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CHEMOKINE; MONOCLONAL ANTIBODY; RANTES; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN SPECIFICITY; ARTICLE; CELL INFILTRATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DEMYELINATION; DISEASE SEVERITY; ENCEPHALOMYELITIS; LEUKOCYTE; LYMPHOCYTE SUBPOPULATION; MACROPHAGE ACTIVATION; MOTOR PERFORMANCE; MOUSE; MULTIPLE SCLEROSIS; MURINE HEPATITIS CORONAVIRUS; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; T LYMPHOCYTE; WHITE MATTER;

EID: 1642317079     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.7.4018     Document Type: Article

References (52)

1. Prat, E., and R. Martin. 2002. The immunopathogenesis of multiple sclerosis. J. Rehabil. Res. Dev. 39:187.
2. Compston, A., and A. Coles. 2002. Multiple sclerosis. Lancet 359:1221.
3. Owens, T. 2003. The enigma of multiple sclerosis: inflammation and neurodegeneration cause heterogenous dysfunction and damage. Curr. Opin. Neurol. 16:259.
4. Lucchinetti, C., W. Bruck, J. Parisi, B. Scheithauer, M. Rodriguez, and H. Lassmann. 2000. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann. Neurol. 47:707.
5. Babcock, A., and T. Owens. 2003. Chemokines in experimental autoimmune encephalomyelitis and multiple sclerosis. Adv. Exp. Med. Biol. 520:120.
6. Ransohoff, R. M. 2002. The chemokine system in neuroinflammation: an update. J. Infect. Dis. 186:S152.
7. + T cells are increased in multiple sclerosis and their ligands MIP-1α and IP-10 are expressed in demyelinating brain lesions. Proc. Natl. Acad. Sci. USA 96:6873.
8. Boven, L. A., L. Montagne, H. S. Nottet, and C. J. De Groot. 2000. Macrophage inflammatory protein-1α (MIP-1α), MIP-1β, and RANTES mRNA semiquantification and protein expression in active demyelinating multiple sclerosis (MS) lesions. Clin. Exp. Immunol. 122:257.
9. Sorensen, T. L., M. Tani, J. Jensen, V. Pierce, C. Lucchinetti, V. A. Folcik, S. Qin, J. Rottman, F. Sellebjerg, R. M. Strieter, et al. 1999. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J. Clin. Invest. 103:807.
10. Zang, Y. C., J. B. Halder, A. K. Samanta, J. Hong, V. M. Rivera, and J. Z. Zhang. 2001. Regulation of chemokine receptor CCR5 and production of RANTES and MIP-1α by interferon-β. J. Neuroimmunol. 112:174.
11. Zang, Y. C., A. K. Samanta, J. B. Halder, J. Hong, M. V. Tejada-Simon, V. M. Rivera, and J. Z. Zhang. 2000. Aberrant T cell migration toward RANTES and MIP-1α in patients with multiple sclerosis: overexpression of chemokine receptor CCR5. Brain 123:1874.
12. Kivisakk, P., C. Trebst, D. J. Eckstei, A. P. Kerza-Kwiateck, and R. M. Ransohoff. 2001. Chemokine-based therapies for MS: how do we get there from here? Trends Immunol. 22:591.
13. Ajuebor, M. N., M. G. Swain, and M. Perretti. 2002. Chemokines as novel therapeutic targets in inflammatory diseases. Biochem. Pharmacol. 63:1191.
14. Lane, T. E., and M. J. Buchmeier. 1997. Murine coronavirus infection: a paradigm for virus-induced demyelinating disease. Trends Microbiol. 5:9.
15. Haring, J., and S. Perlman. 2001. Mouse hepatitis virus. Curr. Opin. Microbiol. 4:462.
16. Matthews, A. E., S. R. Weiss, and Y. Patterson. 2002. Murine hepatitis virus: a model for virus-induced CNS demyelination. J. Neurovirol. 8:76.
17. + T cells and RANTES in virus-induced central nervous system inflammation and demyelination. J. Virol. 74:1415.
18. Pearce, B., M. Hobbs, T. McGraw, and M. Buchmeier. 1994. Cytokine induction during T cell-mediated clearance of mouse hepatitis virus from neurons in vivo. J. Virol. 68:5483.
19. + T cells. J. Immunol. 160: 2896.
20. Lin, M. T., D. R. Hinton, and S. A. Stohlman. 1997. Mouse hepatitis virus is cleared from the central nervous system in mice lacking perforin-mediated cytolysis. J. Virol. 71:383.
21. Parra, B., M. Lin, S. Stohlman, C. C. Bergmann, R. Atkinson, and D. R. Hinton. 2000. Contributions of Fas-Fas ligand interactions to the pathogenesis of mouse hepatitis virus in the central nervous system. J. Virol. 74:2447.
22. Wang, F. I., S. A. Stohlman, and J. O. Fleming. 1990. Demyelination induced by murine hepatitis virus JHM strain (MHV-4) is immunologically mediated. J. Neuroimmunol. 30:31.
23. Wu, G. F., and S. Perlman. 1999. Macrophage infiltration, but not apoptosis, is correlated with immune-mediated demyelination following murine infection with a neurotropic coronavirus. J. Virol. 73:8771.
24. Wu, G. F., A. A. Dandekar, L. Pewe, and S. Perlman. 2000. CD4 and CD8 T cells have redundant but not identical roles in virus-induced demyelination. J. Immunol. 165:2278.
25. Glass, W. G., M. T. Liu, W. A. Kuziel, and T. E. Lane. 2001. Reduced macrophage infiltration and demyelination in mice lacking the chemokine receptor CCR5 following infection with a neurotropic coronavirus. Virology 288:8.
26. + T cells during virus-induced central nervous system disease. J. Virol. 77:191.
27. + T cells following coronavirus infection of the central nervous system. Virology 312:407.
28. Kennedy, K. J., R. M. Strieter, S. L. Kunkel, N. W. Lukacs, and W. J. Karpus. 1998. Acute and relapsing experimental autoimmune encephalomyelitis are regulated by differential expression of the CC chemokines macrophage inflammatory protein-1α and monocyte chemotactic protein-1. J. Neuroimmunol. 92:98.
29. Burdick, M. D., S. L. Kunkel, P. M. Lincoln, C. A. Wilke, and R. M. Strieter. 1993. Specific ELISAs for the detection of human macrophage inflammatory protein-1α and β. Immunol. Invest. 22:441.
30. Galfre, G., S. C. Howe, C. Milstein, G. W. Butcher, and J. C. Howard. 1977. Antibodies to major histocompatibility antigens produced by hybrid cell lines. Nature 266:550.
31. + T cell epitope within the M protein of a neurotropic coronavirus. Virology 208:173.
32. + T-cell epitopes within the surface glycoprotein of a neurotropic coronavirus and correlation with pathogenicity. J. Virol. 69:8127.
33. Proost, P., E. Schutyser, P. Menten, S. Struyf, A. Wuyts, G. Opdenakker, M. Detheux, M. Parmentier, C. Durinx, A. M. Lambeir, et al. 2001. Aminoterminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties. Blood 98:3554.
34. Wang, F. I., J. O. Fleming, and M. M. Lai. 1992. Sequence analysis of the spike protein gene of murine coronavirus variants: study of genetic sites affecting neuropathology. Virology 186:742.
35. Liu, M. T., H. S. Keirstead, and T. E. Lane. 2001. Neutralization of the chemokine CXCL10 reduces inflammatory cell invasion and demyelination and improves neurological function in a viral model of multiple sclerosis. J. Immunol. 167:4091.
36. Chen, B. P., W. A. Kuziel, and T. E. Lane. 2001. Lack of CCR2 results in increased mortality and impaired leukocyte activation and trafficking following infection of the central nervous system with a neurotropic coronavirus. J. Immunol. 167:4585.
37. +-T-cell effector function and migration following viral infection. J. Virol. 77:4004.
38. + T cell subset that responds to viral glycoproteins. Virology 187:443.
39. Xue, S., and S. Perlman. 1997. Antigen specificity of CD4 T cell response in the central nervous system of mice infected with mouse hepatitis virus. Virology 238:68.
40. b-restricted cytotoxic T cell response. J. Gen. Virol. 77:315.
41. Lane, T. E., V. C. Asensio, N. Yu, A. D. Paoletti, I. L. Campbell, and M. J. Buchmeier. 1998. Dynamic regulation of α and β chemokine expression in the central nervous system during mouse hepatitis virus-induced demyelinating disease. J. Immunol. 160:970.
42. Haring, J. S., L. L. Pewe, and S. Perlman. 2001. High-magnitude, virus-specific CD4 T-cell response in the central nervous system of coronavirus-infected mice. J. Virol. 75:3043.
43. Pewe, L., J. Haring, and S. Perlman. 2002. CD4 T-cell mediated demyelination is increased in the absence of γ-interferon in mice infected with mouse hepatitis virus. J. Virol. 76:7329.
44. Pewe, L., and S. Perlman. 2002. CD8 T cell-mediated demyelination is IFN-γ dependent in mice infected with a neurotropic coronavirus. J. Immunol. 168:1547.
45. Liu, M. T., D. Armstrong, T. A. Hamilton, and T. E. Lane. 2001. Expression of Mig (monokine induced by interferon-γ) is important in T lymphocyte recruitment and host defense following viral infection of the central nervous system. J. Immunol. 166:1790.
46. Liu, M. T., B. P. Chen, P. Oertel, M. J. Buchmeier, D. Armstrong, T. A. Hamilton, and T. E. Lane. 2000. The T cell chemoattractant IFN-inducible protein 10 is essential in host defense against viral-induced neurologic disease. J. Immunol. 165:2327.
47. Rossi, D., and A. Zlotnik. 2000. The biology of chemokines and their receptors. Annu. Rev. Immunol. 18:217.
48. Sallusto, F., C. R. Mackay, and A. Lanzavecchia. 2000. The role of chemokine receptors in primary, effector, and memory immune responses. Annu. Rev. Immunol. 18:593.
49. Haring, J. S., and S. Perlman. 2003. Bystander CD4 T cells do not mediate demyelination in mice infected with a neurotropic coronavirus. J. Neuroimmunol. 137:42.
50. Haring, J. S., L. L. Pewe, and S. Perlman. 2002. Bystander CD8 T cell-mediated demyelination after viral infection of the central nervous system. J. Immunol. 169:1550.
51. Nelson, P. J., J. M. Pattison, and A. M. Krensky. 1997. Gene expression of RANTES. Methods Enzymol. 287:148.
52. Trifilo, M. J., C. Montalto-Morrison, L. N. Stiles, K. R. Hurst, J. L. Hardison, J. E. Manning, P. S. Masters, and T. E. Lane. 2004. CXC chemokine ligand 10 controls viral infection in the central nervous system: evidence for a role in innate immune response through recruitment and activation of natural killer cells. J. Virol. 78:585.